sameh shaheen (@samehshaheen) header
sameh shaheen (@samehshaheen) profile picture

prof of cardiology #ainshamsuniversity immediate past president of the Egyptian society of cardiology

Cairo, Egypt
Joined July 2009
Photo by sameh shaheen (@samehshaheen)Photo by sameh shaheen (@samehshaheen)Photo by sameh shaheen (@samehshaheen)Photo by sameh shaheen (@samehshaheen)Photo by sameh shaheen (@samehshaheen)Photo by sameh shaheen (@samehshaheen)Photo by sameh shaheen (@samehshaheen)Photo by sameh shaheen (@samehshaheen)Photo by sameh shaheen (@samehshaheen)Photo by sameh shaheen (@samehshaheen)
sameh shaheen retweeted
In case you missed it, here are all late breaking clinical trial results from #ScientificSessions26.
3
51
142
9,790
sameh shaheen retweeted
Presented at #TCT2026: In a randomized trial, CCTA-guided PCI with structured preprocedural planning and intraprocedural guidance was noninferior to intravascular ultrasound–guided PCI with respect to target-vessel failure at 12 months. Full P4 trial results: nej.md/48jfVly @crfheart
4
86
18
248
36,316
sameh shaheen retweeted
🔥#TCT2026 Late-breaking Trials🔥: PROGRESS 🔗 pcronline.com/News/Congress-… @AsherElad reviews the primary results of this randomised controlled trial that evaluated TAVR in patients with moderate aortic stenosis with at-risk features Presented by @PhilGenereuxMD in San Diego, and published simultaneously in the @NEJM #interventionalcardiology #TAVI #clinicalresearch #science
7
10
925
sameh shaheen retweeted
PROGRESS presented at #TCT2026: Among patients with moderate aortic stenosis and at-risk features, a TAVR strategy was superior to clinical surveillance in reducing the 2-year incidence of death or HF events. The primary endpoint was largely driven by HF hospitalizations, in the context of an unavoidable open-label design. A highly selected population, enriched for risk factors. Medical therapy may also have been suboptimal relative to current standards or evolving evidence. Finally, does intervening earlier in the natural history of the disease mean starting the durability clock sooner than necessary? nejm.org/doi/full/10.1056/NE…
9
32
1
144
23,856
sameh shaheen retweeted
🚨JUST PUBLISHED #TCT2026 Could TAVR offer a new treatment option for severe pure aortic regurgitation? ahajrnls.org/4zm3Ckw
4
26
85
8,921
sameh shaheen retweeted
Original Article: TAVR in Patients with Moderate Aortic Stenosis and High-Risk Features (PROGRESS trial) nej.md/4eUv9kA #TCT2026 | @crfheart
18
65
13,328
sameh shaheen retweeted
It is my honor and privilege to be headed to the US Senate to serve the great state of Michigan.  Michigan, we did what they said couldn’t be done. We won. Together. Now the real work begins.
11,463
33,618
2,523
238,212
3,569,007
sameh shaheen retweeted
I will never forgive the Ballon D’or for placing Mohamed Salah 4th based on having the greatest individual season in Premier League history.
74
772
30
8,983
154,314
💡 Revascularization of coronary artery disease in heart failure When does revascularization improve outcomes in patients with #HeartFailure ❓ 👉ow.ly/k12j50ZIwSl @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd #EJHF
1
52
1
172
12,679
sameh shaheen retweeted
In case you missed it, here are all late-breaking trial results from #ESCCongress
1
116
4
301
19,937
Sharing the ONE LINER highlights from all the clinical trials presented at #ESCCongress2026 across all spectrum of cardiology 🫀⭐️! So many outstanding IC trials 🤩Congratulations @escardio for a phenomenal advancement of science to next level! 👏 ♥️ #FIT @ESC_Journals @ACCinTouch @NEJM @JAMACardio @JACCJournals @TCTMD @TheLancet @BeaumontIC @RyanMadderMD @IvanHansonMD @amrabbasmd @SimonDixonMBChB @AhmadJabri8
1
10
29
2,240
sameh shaheen retweeted
🔥#ESCCongress 🔥2026 Hot Lines: ISOLEDS - IVUS vs OCT guidance for PCI of distal left main bifurcation lesions 🔗pcronline.com/News/Congress-… @Sticchi_Alex & @ANazmiCalik provide their take on the results of this trial, which were presented by Yong Zeng at ESC Congress 2026 in Munich. #interventionalcardiology #clinicalresearch
2
13
1
27
3,059
sameh shaheen retweeted
Ten ESC 2026 trials most likely to change practice. Sham-controlled ablation, statins after 70, and a tricuspid result with an NNT of 4. #ESCCongress #cardiotwitter
1
2
154
sameh shaheen retweeted
أطفال إندونيسيون يشعلون منصات التواصل بمحاكاة ساخرة لمباراة مصر والأرجنتين وفضيحة التحكيم
40
884
36
3,763
114,337
sameh shaheen retweeted
What a finish from Emam Ashour 💥 His first international goal puts Egypt in front against Belgium!
6
7
2
80
11,600
🚨| NEW: Mohamed Salah becomes the FIRST African player on record to register a FIFA World Cup goal involvement on their birthday (since 1966). 🌟🇪🇬 Salah assisted Egypt's opening goal against Belgium on his 34th birthday. [@OptaJoe]
I will still never forget just how good this Mo Salah goal was against Man City 😮‍💨🇪🇬 One last dance at the World Cup for the King 👑
4
14
118
7,028
sameh shaheen retweeted
🚨🌎 EMAM ASHOUR OPENS THE SCORING FOR EGYPT! WHAT A GOAL! 🤯 Belgium 0-1 Egypt. teapawt.net/brownkingys/status/206…
139
823
145
10,328
525,568
sameh shaheen retweeted
The population is >80 yo, in nursing facility, and SBP <130 on 2 or more antiHTNives. Reducing meds (if no cross-indications like B- blocker for tachycardia) was safe. Overall, this looks like a pretty limited population eligible for de-escalation.
Should we reduce antihypertensives in the elderly? RETREAT-FRAIL unlikely to have a clinically relevant effect on all-cause mortality, and has no apparent effect on functional capacities, MACE, or on other SAE. #ESCCongress #WCCardio #HypertensionTreatment
1
1
174
#ESCCongress Great late breaker presentation by @mmamas1973 1️⃣ SURMOUNT-5 (72 weeks, n=751):
🔻 Tirzepatide led to superior weight reduction vs semaglutide
🔻 Greater improvements in SBP (-10.2 vs -7.7 mmHg) & LDL (-7.8 vs -5.9 mg/dL)
 2️⃣ Post-hoc SURMOUNT-5 analysis:
📉 Lower predicted 10-yr CVD risk with tirzepatide vs semaglutide
🌍 Projection: millions of preventable primary CVD events globally
 3️⃣ Real-world & data align:
✅ Tirzepatide linked with lower risk of MI, stroke, & all-cause mortality
✅ Potential 2M preventable CVD events over 10 years with tirzepatide vs 1.5M with semaglutide
 4️⃣ Key takeaway: In adults with obesity (no diabetes/CVD), tirzepatide may provide greater CVD risk reduction than semaglutide. @mirvatalasnag @DBelardoMD
5
81
5
225
22,008
sameh shaheen retweeted
Just out at #ESCCongress: Our ESC–EAPCI Atlas of Interventional Cardiology shows — 1️⃣ PCI makes up >90% of all CV interventions 2️⃣ Lower-income regions are closing the gap in primary PCI 3️⃣ But the gap in valve interventions is widening” link to paper here: academic.oup.com/eurheartj/a… Please that UK data is part of this #ESC2025
1
29
68
5,067